Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Calistoga Pharmaceuticals, a developer of medicines for the treatment of cancer and inflammatory diseases, has appointed Carol Gallagher as its new CEO.
Subscribe to our email newsletter
Dr Gallagher joins Calistoga Pharmaceuticals after recently serving as president and CEO of Metastatix, a private oncology company. Prior to that, Dr Gallagher held senior leadership roles at Anadys Pharmaceuticals as senior vice president of corporate development and CancerVax as vice president of product planning.
Michael Gallatin, president of Calistoga, said: “Carol has been instrumental in strategic planning and corporate development across multiple therapeutic areas and has demonstrated her ability to foster alliances with leading firms. With our first compounds entering clinical trials and our business development activities underway, Carol’s experience and leadership will complement our experienced scientific and operational team.”